Marc Tebruegge
Overview
Explore the profile of Marc Tebruegge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lange C, Bothamley G, Gunther G, Guglielmetti L, Kontsevaya I, Kuksa L, et al.
Pathog Immun
. 2025 Mar;
10(2):1-45.
PMID: 40062355
Background: In the field of tuberculosis and non-tuberculous mycobacterial (NTM) disease we are looking back on an exciting year 2024 with more than 10,000 publications listed in PubMed. Methods: Our...
2.
Martinez-Planas A, Baquero-Artigao F, Mendez-Echevarria A, Del Rosal T, Rodriguez-Molino P, Toro-Rueda C, et al.
Emerg Infect Dis
. 2025 Mar;
31(3):536-546.
PMID: 40023802
We describe the epidemiology, diagnosis, and management of nontuberculous mycobacterial lymphadenitis cases detailed in a 28-year (1996-2023) multicenter cohort from Spain. The case numbers remained stable during the initial prospective...
3.
Topitz D, Rothensteiner M, Baier-Grabner S, Langthaler M, Reithmayr S, Zacharasiewicz A, et al.
Klin Padiatr
. 2024 Oct;
237(2):99-101.
PMID: 39406362
No abstract available.
4.
Lopez-Suarez A, Santos-Sebastian M, Hernanz-Lobo A, Rincon-Lopez E, Aguilera-Alonso D, Saavedra-Lozano J, et al.
J Microbiol Immunol Infect
. 2024 Sep;
57(6):937-946.
PMID: 39271436
Introduction: Immune-based diagnostic tests for tuberculosis (TB) have suboptimal sensitivity in children and cannot differentiate between latent infection (LTBI) and active disease. This study evaluated the diagnostic potential of a...
5.
Rothensteiner M, Leeb F, Gotzinger F, Tebruegge M, Zacharasiewicz A
Children (Basel)
. 2024 Aug;
11(8).
PMID: 39201907
(1) Background: Data on persisting symptoms after SARS-CoV-2 infection in children and adolescents are conflicting. Due to the absence of a clear pathophysiological correlate and a definitive diagnostic test, the...
6.
Neudecker D, Fritschi N, Sutter T, Lu L, Lu P, Tebruegge M, et al.
BMC Infect Dis
. 2024 Jun;
24(1):629.
PMID: 38914934
No abstract available.
7.
Neudecker D, Fritschi N, Sutter T, Lu L, Lu P, Tebruegge M, et al.
BMC Infect Dis
. 2024 May;
24(1):481.
PMID: 38730343
Background: Tuberculosis (TB) poses a major public health challenge, particularly in children. A substantial proportion of children with TB disease remain undetected and unconfirmed. Therefore, there is an urgent need...
8.
Rodriguez-Molino P, Tebruegge M, Noguera-Julian A, Neth O, Fidler K, Brinkmann F, et al.
Clin Infect Dis
. 2024 Apr;
79(1):215-222.
PMID: 38568992
Background: In high-resource settings, the survival of children with immunocompromise (IC) has increased and immunosuppressive therapies are increasingly being used. This study aimed to determine the clinical characteristics, performance of...
9.
Schiff H, Walker N, Ugarte-Gil C, Tebruegge M, Manousopoulou A, Garbis S, et al.
JCI Insight
. 2024 Mar;
9(8).
PMID: 38512356
BACKGROUNDNovel biomarkers to identify infectious patients transmitting Mycobacterium tuberculosis are urgently needed to control the global tuberculosis (TB) pandemic. We hypothesized that proteins released into the plasma in active pulmonary...
10.
Soler-Garcia A, Gamell A, Monsonis M, Korta-Murua J, Espiau M, Rincon-Lopez E, et al.
Pediatr Infect Dis J
. 2023 Aug;
42(11):1017-1020.
PMID: 37566889
We studied 295 children (tuberculosis disease, n = 159; latent tuberculosis infection, n = 136) with positive QuantiFERON-TB Gold-Plus assay results. No significant differences between first and second antigen tube...